American Century Companies Inc. decreased its holdings in shares of Monsanto (NYSE:MON) by 48.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 794,770 shares of the basic materials company’s stock after selling 752,228 shares during the period. American Century Companies Inc.’s holdings in Monsanto were worth $92,813,000 at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in MON. Tower Research Capital LLC TRC boosted its position in shares of Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after purchasing an additional 750 shares in the last quarter. Americafirst Capital Management LLC bought a new stake in shares of Monsanto during the 3rd quarter valued at about $148,000. S&CO Inc. bought a new stake in shares of Monsanto during the 3rd quarter valued at about $216,000. McKinley Carter Wealth Services Inc. bought a new stake in shares of Monsanto during the 4th quarter valued at about $218,000. Finally, Corundum Group Inc. bought a new stake in shares of Monsanto during the 3rd quarter valued at about $228,000. Institutional investors own 75.62% of the company’s stock.
In related news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the transaction, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at approximately $6,772,277.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.79% of the stock is currently owned by corporate insiders.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01). Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. During the same period last year, the company posted $0.21 earnings per share. The firm’s quarterly revenue was up .3% compared to the same quarter last year. analysts anticipate that Monsanto will post 5.76 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, April 6th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Thursday, April 5th. Monsanto’s dividend payout ratio (DPR) is currently 39.93%.
Several equities research analysts recently commented on MON shares. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Royal Bank of Canada restated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research report on Wednesday, November 15th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a research report on Tuesday, January 16th. Finally, Wells Fargo & Co restated a “market perform” rating and set a $128.00 target price (up previously from $118.00) on shares of Monsanto in a research report on Wednesday, January 17th. Eleven research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $127.30.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2018/02/10/monsanto-mon-shares-sold-by-american-century-companies-inc.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.